MDS1\/EVI1_NN
enhances_VBZ
TGF-beta1_NN
signaling_NN
and_CC
strengthens_VBZ
its_PRP$
growth-inhibitory_JJ
effect_NN
but_CC
the_DT
leukemia-associated_JJ
fusion_NN
protein_NN
AML1\/MDS1\/EVI1_NN
,_,
product_NN
of_IN
the_DT
t_NN
-LRB-_-LRB-
3_CD
;_:
21_CD
-RRB-_-RRB-
,_,
abrogates_VBZ
growth-inhibition_NN
in_IN
response_NN
to_TO
TGF-beta1_NN
._.

MDS1\/EVI1_NN
,_,
located_JJ
on_IN
chromosome_NN
3_CD
band_NN
q26_NN
,_,
encodes_VBZ
a_DT
zinc-finger_JJ
DNA-binding_JJ
transcription_NN
activator_NN
not_RB
detected_VBN
in_IN
normal_JJ
hematopoietic_JJ
cells_NNS
but_CC
expressed_VBN
in_IN
several_JJ
normal_JJ
tissues_NNS
._.

MDS1\/EVI1_NN
is_VBZ
inappropriately_RB
activated_VBN
in_IN
myeloid_JJ
leukemias_NNS
following_VBG
chromosomal_JJ
rearrangements_NNS
involving_VBG
band_NN
3q26_NN
._.

The_DT
rearrangements_NNS
lead_VBP
either_RB
to_TO
gene_NN
truncation_NN
,_,
and_CC
to_TO
expression_NN
of_IN
the_DT
transcription_NN
repressor_NN
EVI1_NN
,_,
as_IN
seen_VBN
in_IN
the_DT
t_NN
-LRB-_-LRB-
3_CD
;_:
3_CD
-RRB-_-RRB-
-LRB-_-LRB-
q21_NN
;_:
q26_NN
-RRB-_-RRB-
and_CC
inv_NN
3_CD
-LRB-_-LRB-
q21q26_NN
-RRB-_-RRB-
,_,
or_CC
to_TO
gene_NN
fusion_NN
,_,
as_IN
seen_VBN
in_IN
the_DT
t_NN
-LRB-_-LRB-
3_CD
;_:
21_CD
-RRB-_-RRB-
-LRB-_-LRB-
q26_NN
;_:
q22_NN
-RRB-_-RRB-
which_WDT
results_VBZ
in_IN
the_DT
fusion_NN
protein_NN
AML1\/MDS1\/EVI1_NN
._.

This_DT
fusion_NN
protein_NN
contains_VBZ
the_DT
DNA-binding_JJ
domain_NN
of_IN
the_DT
transcription_NN
factor_NN
AML1_NN
fused_VBN
in-frame_RB
to_TO
the_DT
entire_JJ
MDS1\/EVI1_NN
with_IN
the_DT
exclusion_NN
of_IN
its_PRP$
first_JJ
12_CD
amino_NN
acids_NNS
._.

In_IN
this_DT
report_NN
,_,
we_PRP
have_VBP
analyzed_VBN
the_DT
response_NN
of_IN
the_DT
hematopoietic_JJ
precursor_NN
cell_NN
line_NN
32Dcl3_NN
,_,
expressing_VBG
either_CC
the_DT
normal_JJ
protein_NN
MDS1\/EVI1_NN
or_CC
the_DT
fusion_NN
protein_NN
AML1\/MDS1\/EVI1_NN
,_,
to_TO
factors_NNS
that_WDT
control_VBP
cell_NN
differentiation_NN
or_CC
cell_NN
replication_NN
._.

The_DT
32Dcl3_NN
cells_NNS
are_VBP
IL-3-dependent_JJ
for_IN
growth_NN
and_CC
they_PRP
differentiate_VBP
into_IN
granulocytes_NNS
when_WRB
exposed_VBN
to_TO
G-CSF_NN
._.

They_PRP
are_VBP
growth-inhibited_VBN
by_IN
TGF-beta1_NN
._.

We_PRP
show_VBP
that_IN
whereas_IN
the_DT
expression_NN
of_IN
MDS1\/EVI1_NN
has_VBZ
no_DT
effect_NN
on_IN
granulocytic_JJ
differentiation_NN
induced_VBN
by_IN
G-CSF_NN
,_,
expression_NN
of_IN
AML1\/MDS1\/EVI1_NN
blocks_VBZ
differentiation_NN
resulting_VBG
in_IN
cell_NN
death_NN
._.

This_DT
effect_NN
is_VBZ
similar_JJ
to_TO
that_DT
previously_RB
described_VBN
by_IN
others_NNS
for_IN
32Dcl3_NN
cells_NNS
that_WDT
express_VBP
transgenic_JJ
Evil_NN
._.

Furthermore_RB
,_,
we_PRP
show_VBP
that_IN
whereas_IN
the_DT
expression_NN
of_IN
the_DT
fusion_NN
protein_NN
AML1\/MDS1\/EVI1_NN
completely_RB
abrogates_VBZ
the_DT
growth-inhibitory_JJ
effect_NN
of_IN
TGF-beta1_NN
and_CC
allows_VBZ
32Dcl3_NN
cells_NNS
to_TO
proliferate_VB
,_,
expression_NN
of_IN
the_DT
normal_JJ
protein_NN
MDS1\/EVI1_NN
has_VBZ
the_DT
opposite_JJ
effect_NN
,_,
and_CC
it_PRP
strengthens_VBZ
the_DT
response_NN
of_IN
cells_NNS
to_TO
the_DT
growth-inhibitory_JJ
effect_NN
of_IN
TGF-beta1_NN
._.

By_IN
using_VBG
the_DT
yeast_NN
two-hybrid_JJ
system_NN
,_,
we_PRP
also_RB
show_VBP
that_IN
EVI1_NN
-LRB-_-LRB-
contained_VBN
in_IN
its_PRP$
entirety_NN
in_IN
MDS1\/EVI1_NN
and_CC
AML1\/MDS1\/EVI1_NN
-RRB-_-RRB-
physically_RB
interacts_VBZ
with_IN
SMAD3_NN
,_,
which_WDT
is_VBZ
an_DT
intracellular_JJ
mediator_NN
of_IN
TGF-beta1_NN
signaling_NN
._.

Finally_RB
,_,
we_PRP
have_VBP
correlated_VBN
the_DT
response_NN
of_IN
the_DT
cells_NNS
to_TO
G-CSF_NN
or_CC
TGF-beta1_NN
with_IN
the_DT
ability_NN
of_IN
the_DT
normal_JJ
and_CC
fusion_NN
proteins_NNS
to_TO
activate_VB
or_CC
repress_VB
promoters_NNS
which_WDT
they_PRP
can_MD
directly_RB
regulate_VB
by_IN
binding_NN
to_TO
the_DT
promoter_NN
site_NN
._.

We_PRP
propose_VBP
that_IN
mutations_NNS
of_IN
MDS1\/EVI1_NN
either_CC
by_IN
gene_NN
truncation_NN
resulting_VBG
in_IN
the_DT
transcription_NN
repressor_NN
EVI1_NN
or_CC
by_IN
gene_NN
fusion_NN
to_TO
AML1_NN
lead_VBP
to_TO
an_DT
altered_JJ
cellular_JJ
response_NN
to_TO
growth_NN
and_CC
differentiation_NN
factors_NNS
that_WDT
could_MD
result_VB
in_IN
leukemic_JJ
transformation_NN
._.

The_DT
different_JJ
response_NN
of_IN
myeloid_JJ
cells_NNS
ectopically_RB
expressing_VBG
the_DT
normal_JJ
or_CC
the_DT
fusion_NN
protein_NN
to_TO
G-CSF_NN
and_CC
TGF-beta1_NN
could_MD
depend_VB
on_IN
the_DT
different_JJ
transactivation_NN
properties_NNS
of_IN
these_DT
proteins_NNS
resulting_VBG
in_IN
divergent_JJ
expression_NN
of_IN
downstream_JJ
genes_NNS
regulated_VBN
by_IN
the_DT
two_CD
proteins_NNS
._.

